Tonix Pharmaceuticals Holding Corp. (TNXP) › Operating Cash FlowTonix Pharmaceuticals Holding Corp. (TNXP) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$1.23M2011: -$2.64M2016: -$37.31M2017: -$19.13M2018: -$23.97M2019: -$26.68M2020: -$48.57M2021: -$75.56M2022: -$98.05M2023: -$102.00M2024: -$60.92M2025: -$99.84M-$99.84M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$99.84M-63.9%2024-$60.92M+40.3%2023-$102.00M-4.0%2022-$98.05M-29.8%2021-$75.56M-55.6%2020-$48.57M-82.0%2019-$26.68M-11.3%2018-$23.97M-25.3%2017-$19.13M+48.7%2016-$37.31M—2011-$2.64M-113.9%2010-$1.23M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share